13F Portfolios

SOUTHEASTERN ASSET MANAGEMENT INC/TN/ — REGENERON PHARMACEUTICALS, INC. REGN: Quarterly 13F Position History

SOUTHEASTERN ASSET MANAGEMENT INC/TN/ has reported REGENERON PHARMACEUTICALS, INC. (REGN) on 5 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2025. As of Q1 2026, the position is sized at 130,662 shares ($101.0M market value, 4.97% of the equity book). Quarter-over-quarter share count change: 35,130 (-21.2%) .

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 130,662 35,130 -21.2% $101.0M 4.97% $772.64
Q4 2025 165,792 +21,185 +14.7% $128.0M 5.70% $771.87
Q3 2025 144,607 15,974 -9.9% $81.3M 4.15% $562.27
Q2 2025 160,581 +45,701 +39.8% $84.3M 4.25% $525.00
Q1 2025 114,880 $72.9M 3.88% $634.23

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did SOUTHEASTERN ASSET MANAGEMENT INC/TN/ first disclose a REGN position in 13F-HR filings?

SOUTHEASTERN ASSET MANAGEMENT INC/TN/ first reported REGENERON PHARMACEUTICALS, INC. (REGN) on its 13F-HR filing for the period ending 2025-03-31 (Q1 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.

What was SOUTHEASTERN ASSET MANAGEMENT INC/TN/'s most recent quarter-over-quarter share-count change in REGN?

Between Q4 2025 and Q1 2026, SOUTHEASTERN ASSET MANAGEMENT INC/TN/ reduced its REGN position by 35,130 shares (-21.2%), leaving 130,662 shares at a market value of $101.0M.

Does the implied price-per-share represent SOUTHEASTERN ASSET MANAGEMENT INC/TN/'s cost basis in REGN?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.